Selection of the Brain-Dead Potential Organ Donor

  • Kadiyala V. Ravindra
  • Keri E. Lunsford
  • Paul C. Kuo
Chapter

Abstract

Over the past decade, the utilization of organs from older and other donors with compromised physiology has become commonplace. This has been achieved with satisfactory results. There has been significant progress in the assessment and resuscitation of expanded criteria organs. This chapter discusses the selection of donors for both thoracic and abdominal organ transplantation.

Keywords

Sugar Obesity Catheter Hepatitis Filtration 

References

  1. 1.
    Kulkarni S, Cronin 2 DC. Ethical tensions in solid organ transplantation: the price of success. World J Gastroenterol. 2006;12:3259–64.PubMedGoogle Scholar
  2. 2.
    Attia M, Silva MA, Mirza DF. The marginal liver donor—an update. Transpl Int. 2008;21:713–24.PubMedCrossRefGoogle Scholar
  3. 3.
    Pascual J, Zamora J, Pirsch JD. A systematic review of kidney transplantation from expanded criteria donors. Am J Kidney Dis. 2008;52:553–86.PubMedCrossRefGoogle Scholar
  4. 4.
    Stratta RJ, Rohr MS, Sundberg AK, et al. Intermediate-term outcomes with expanded criteria deceased donors in kidney transplantation: a spectrum or specter of quality? Ann Surg. 2006;243:594–601. discussion-603.PubMedCrossRefGoogle Scholar
  5. 5.
    Stratta RJ, Moore PS, Farney AC, et al. Influence of pulsatile perfusion preservation on outcomes in kidney transplantation from expanded criteria donors. J Am Coll Surg. 2007;204:873–82. discussion 82–4.PubMedCrossRefGoogle Scholar
  6. 6.
    Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6:783–90.PubMedCrossRefGoogle Scholar
  7. 7.
    Botha P. Extended donor criteria in lung transplantation. Curr Opin Organ Transplant. 2009;14:206–10.PubMedCrossRefGoogle Scholar
  8. 8.
    Humar A, Morris M, Blumberg E, et al. Nucleic acid testing (NAT) of organ donors: is the ‘best’ test the right test? A consensus conference report. Am J Transplant. 2010;10:889–99.PubMedCrossRefGoogle Scholar
  9. 9.
    Buell JF, Alloway RR, Steve Woodle E. How can donors with a previous malignancy be evaluated? J Hepatol. 2006;45:503–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Johnson MR, Meyer KH, Haft J, Kinder D, Webber SA, Dyke DB. Heart transplantation in the United States, 1999–2008. Am J Transplant. 2010;10:1035–46.PubMedCrossRefGoogle Scholar
  11. 11.
    Laks H, Marelli D, Fonarow GC, et al. Use of two recipient lists for adults requiring heart transplantation. J Thorac Cardiovasc Surg. 2003;125:49–59.PubMedCrossRefGoogle Scholar
  12. 12.
    Zaroff JG, Rosengard BR, Armstrong WF, et al. Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28–29, 2001, Crystal City, VA. Circulation. 2002;106:836–41.PubMedCrossRefGoogle Scholar
  13. 13.
    Stehlik J, Feldman DS, Brown RN, et al. Interactions among donor characteristics influence post-transplant survival: a multi-institutional analysis. J Heart Lung Transplant. 2010;29:291–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Stoica SC, Satchithananda DK, Charman S, et al. Swan-Ganz catheter assessment of donor hearts: ­outcome of organs with borderline hemodynamics. J Heart Lung Transplant. 2002;21:615–22.PubMedCrossRefGoogle Scholar
  15. 15.
    Forni A, Luciani GB, Chiominto B, Pilati M, Mazzucco A, Faggian G. Impact of donor quality on outcome of heart transplantation. Eur J Cardiothorac Surg. 2010;38(6):788–94.PubMedCrossRefGoogle Scholar
  16. 16.
    Felker GM, Milano CA, Yager JE, et al. Outcomes with an alternate list strategy for heart transplantation. J Heart Lung Transplant. 2005;24:1781–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Lima B, Rajagopal K, Petersen RP, et al. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. Circulation. 2006;114:I27–32.PubMedCrossRefGoogle Scholar
  18. 18.
    Daneshmand MA, Rajagopal K, Lima B, et al. Left ventricular assist device destination therapy versus extended criteria cardiac transplant. Ann Thorac Surg. 2010;89:1205–9. discussion 10.PubMedCrossRefGoogle Scholar
  19. 19.
    Van Raemdonck D, Neyrinck A, Verleden GM, et al. Lung donor selection and management. Proc Am Thorac Soc. 2009;6:28–38.PubMedCrossRefGoogle Scholar
  20. 20.
    Sundaresan S, Trachiotis GD, Aoe M, Patterson GA, Cooper JD. Donor lung procurement: assessment and operative technique. Ann Thorac Surg. 1993;56:1409–13.PubMedCrossRefGoogle Scholar
  21. 21.
    Reyes KG, Mason DP, Thuita L, et al. Guidelines for donor lung selection: time for revision? Ann Thorac Surg. 2010;89:1756–64. discussion 64–5.PubMedCrossRefGoogle Scholar
  22. 22.
    The U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients. 2009 OPTN/SRTR Annual Report. U.S. Department of Health & Human Services; Health Resources and Services Administration. Available at: http://optn.transplant.hrsa.gov/ar2009/default.htm. Accessed 21 October 2011.
  23. 23.
    Merion RM, Ashby VB, Wolfe RA, et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA. 2005;294:2726–33.PubMedCrossRefGoogle Scholar
  24. 24.
    Metzger RA, Delmonico FL, Feng S, Port FK, Wynn JJ, Merion RM. Expanded criteria donors for kidney transplantation. Am J Transplant. 2003;3 Suppl 4:114–25.PubMedCrossRefGoogle Scholar
  25. 25.
    Stratta RJ, Rohr MS, Sundberg AK, et al. Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant. Ann Surg. 2004;239:688–95. discussion 95–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Ruggenenti P, Perico N, Remuzzi G. Ways to boost kidney transplant viability: a real need for the best use of older donors. Am J Transplant. 2006;6:2543–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Moers C, Smits JM, Maathuis MH, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med. 2009;360:7–19.PubMedCrossRefGoogle Scholar
  28. 28.
    Sonnenday CJ, Cooper M, Kraus E, Gage F, Handley C, Montgomery RA. The hazards of basing acceptance of cadaveric renal allografts on pulsatile perfusion parameters alone. Transplantation. 2003;75:2029–33.PubMedCrossRefGoogle Scholar
  29. 29.
    Moore PS, Farney AC, Sundberg AK, et al. Dual kidney transplantation: a case–control comparison with single kidney transplantation from standard and expanded criteria donors. Transplantation. 2007;83:1551–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Deroure B, Kamar N, Depreneuf H, et al. Expanding the criteria of renal kidneys for transplantation: use of donors with acute renal failure. Nephrol Dial Transplant. 2010;25:1980–6.PubMedCrossRefGoogle Scholar
  31. 31.
    Mohanka R, Basu A, Shapiro R, Kayler LK. Single versus en bloc kidney transplantation from pediatric donors less than or equal to 15 kg. Transplantation. 2008;86:264–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, James OF. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology. 1989;9:297–301.PubMedCrossRefGoogle Scholar
  33. 33.
    Borchert DH, Glanemann M, Mogl M, Langrehr J, Neuhaus P. Adult liver transplantation using liver grafts from donors over 70 years of age. Transplant Proc. 2005;37:1186–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant. 2009;9:318–26.PubMedCrossRefGoogle Scholar
  35. 35.
    De Carlis L, Colella G, Sansalone CV, et al. Marginal donors in liver transplantation: the role of donor age. Transplant Proc. 1999;31:397–400.PubMedCrossRefGoogle Scholar
  36. 36.
    Mutimer DJ, Gunson B, Chen J, et al. Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation. 2006;81:7–14.PubMedCrossRefGoogle Scholar
  37. 37.
    Fishbein TM, Fiel MI, Emre S, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation. 1997;64:248–51.PubMedCrossRefGoogle Scholar
  38. 38.
    Angelico M. Donor liver steatosis and graft selection for liver transplantation: a short review. Eur Rev Med Pharmacol Sci. 2005;9:295–7.PubMedGoogle Scholar
  39. 39.
    Ho JK, Harrigan PR, Sherlock CH, et al. Utilization of a liver allograft from a hepatitis B surface antigen positive donor. Transplantation. 2006;81:129–31.PubMedCrossRefGoogle Scholar
  40. 40.
    Velidedeoglu E, Desai NM, Campos L, et al. The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation. 2002;73:582–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Fridell JA, Rogers J, Stratta RJ. The pancreas allograft donor: current status, controversies, and challenges for the future. Clin Transplant. 2010;24:433–49.PubMedCrossRefGoogle Scholar
  42. 42.
    Tuttle-Newhall JE, Krishnan SM, Levy MF, McBride V, Orlowski JP, Sung RS. Organ donation and utilization in the United States: 1998–2007. Am J Transplant. 2009;9:879–93.PubMedCrossRefGoogle Scholar
  43. 43.
    Wood KE, Becker BN, McCartney JG, D’Alessandro AM, Coursin DB. Care of the potential organ donor. N Engl J Med. 2004;351:2730–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Boggi U, Del Chiaro M, Vistoli F, et al. Pancreas transplantation from marginal donors. Transplant Proc. 2004;36:566–8.PubMedCrossRefGoogle Scholar
  45. 45.
    Sutherland DE, Gruessner RW, Dunn DL, et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg. 2001;233:463–501.PubMedCrossRefGoogle Scholar
  46. 46.
    Humar A, Ramcharan T, Kandaswamy R, Gruessner RW, Gruessner AC, Sutherland DE. Technical failures after pancreas transplants: why grafts fail and the risk factors—a multivariate analysis. Transplantation. 2004;78:1188–92.PubMedCrossRefGoogle Scholar
  47. 47.
    Yersiz H, Renz JF, Hisatake GM, et al. Multivisceral and isolated intestinal procurement techniques. Liver Transpl. 2003;9:881–6.PubMedCrossRefGoogle Scholar
  48. 48.
    Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med. 2011;364:1431–40.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Kadiyala V. Ravindra
    • 1
  • Keri E. Lunsford
    • 1
  • Paul C. Kuo
    • 2
  1. 1.Division of Transplantation, Department of SurgeryDuke UniversityDurhamUSA
  2. 2.Department of SurgeryLoyola University Medical CenterMaywoodUSA

Personalised recommendations